In the past week, several key developments were reported by the FDA in the field of radiology. Notable advancements include the clearance of new AI software that estimates fractional flow reserve (FFR) from coronary CT angiography (CCTA) scans, as well as a machine learning module for a musculoskeletal ultrasound platform. Additionally, there is new brain MRI software that may assist in predicting the long-term progression of mild cognitive impairment towards Alzheimer’s disease.
Sun, 25 Oct 2026 10:04:30 GMT | Diagnostic Imaging